The company has adapted the “no research, development only model” and the “networked pharma model” for new drug development. We license in drug candidates ranging from preclinical to clinical stages and further develop the projects in territories. PharmaEngine focuses on niche markets, and current projects are mainly for cancer treatment. The core competencies of the company include win-win partnership, project management and market-driven drug development strategy.